Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Concerning symptoms warranting immediate provider contact include severe chills unresponsive to additional clothing or heating, chills accompanied by fever above 100.4F, persistent chills lasting more than 2 weeks, or thermoregulatory symptoms that worsen over time
Patients on the 6 mg and 12 mg doses lost a mean of 7.5% and 8.4% respectively, compared to 2.1% in the placebo group
Patients who are less than 18 years old Pregnant or breastfeeding mothers BMI of 25 or lower Patients with hypersensitivity to semaglutide Patients with a history of pancreatitis, medullary thyroid carcinoma, or endocrine neoplasia syndrome Each patient reacts to weight loss medications differently
In 2026 the picture is more complicated than ever: employer coverage has plateaued and in some cases reversed, Medicare has launched its first-ever weight loss drug program, and several states have eliminated Medicaid coverage
